News | January 03, 2008

InfoLogix Featured in FOX Business News Interview on Reducing Medication Errors

January 4, 2007 - InfoLogix Inc. was recently featured in a FOX Business News interview about how the company’s mobile technology is helping to solve medication management errors among its 1,400 hospital customers across North America.

The interview with InfoLogix CEO and President David Gulian, originally scheduled to air Dec. 13, aired on FOX Business News Jan. 3, during the “C-Suite Sitdown” segment of the morning show.

Among the many challenges of the nation’s healthcare system, the Institute of Medicine estimates that medication errors harm at least 1.5 million people a year. To reduce errors that can harm patients and lead to lawsuits, Gulian discussed how hospitals across North America are making significant investments in infrastructure that changes the way they provide care and do business.

InfoLogix’s healthcare mobility solutions have been selected by more than 20 percent of hospitals across the U.S. to improve patient safety, reduce medication errors, track critical equipment, and raise the standard of care delivery.

For more information: www.infologixsys.com/TVinterview

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init